ARCHIVES

Bass & Howes Bought By DDB Seattle

This article is from The Cancer Letter archive.

Vol. 28 No. 12 | March 22, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

August 25, 1978

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Funding Opportunities.

May 10, 2002

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014